|
|
|
Vascular Access Market |
| |
Navilyst Medical Announces Global Debut Today : Former Boston
Scientific Business Units Combine to Lead Fluid Management and
Vascular Access Markets
Other Topics:
Medical Database Migration
Navilyst Medical
August 4, 2008
Navilyst Medical, formerly Boston
Scientific’s Fluid Management and Vascular Access businesses,
today announced its new company name following the February 2008
acquisition by Avista Capital Partners, a private equity firm
focused on growth-oriented healthcare, energy and media
companies.
Marlborough, MA -- Navilyst Medical, formerly Boston
Scientific’s Fluid Management and Vascular Access businesses,
today announced its new company namSe following the February
2008 acquisition by Avista Capital Partners, a private equity
firm focused on growth-oriented healthcare, energy and media
companies.
"Navilyst Medical combines the best
attributes of an established medical device
company—market-leading technology, superior clinical data,
experienced leadership and proven worldwide sales and
distribution capabilities. We maintain the singular focus of a
small, eager organization striving to improve patient care while
collaborating with clinicians in the global marketplace,” said
President Dave McClellan. |
| |
|
|
| & |
Navilyst Medical manufactures and markets a
portfolio of fluid management and vascular access products used
during some of the most frequent hospital procedures including
angiography and angioplasty. Navilyst Medical’s Fluid Management
business, including the proprietary NAMIC® line of products
enjoys a leading global market share. Navilyst Medical’s
vascular access products include devices designed to provide
access to the blood stream for patients requiring intravenous
antibiotics, nutrition, chemotherapy, blood sampling and
hemodialysis. The company’s PASV® Technology, with strong
clinical data, is uniquely designed to automatically close after
infusion, disconnection or aspiration, and remain closed during
normal pressure fluctuations, reducing the risk of complications
including catheter-related bloodstream infections.
“At Navilyst Medical we are exclusively dedicated to designing,
developing, manufacturing and marketing high quality products
that make it possible for lifesaving diagnostics, interventions
and drug delivery to occur every day,” said Navilyst Medical’s
McClellan. “We will build upon a strong foundation and look
forward to living up to our new name by navigating change and
being a catalyst for innovation.”
Navilyst Medical employs approximately 800 people, and is
headquartered in Marlborough, MA with an ISO-certified
manufacturing plant in Glens Falls, NY. Products are distributed
in 76 countries and are sold direct in the United States. The
company is on track to launch several new products into the
global marketplace through internal development and strategic
alliances during the upcoming year.
“It is the company’s strategic intent to become the first choice
provider of medical devices for vascular access, and the
diagnosis and treatment of vascular disease. This strong
combination of product heritage and experienced employees able
to execute on this vision captured Avista’s interest in the deal
from the outset. By 2011 the company should look very different
than we do today—and that’s exciting,” added Navilyst Medical
CEO Ron Sparks.
About Navilyst Medical
Navilyst Medical, headquartered in Marlborough, MA, was formed
in February 2008 from Boston Scientific’s Fluid Management and
Vascular Access business units. Its breakthrough products,
including the PASV® Valve Technology, Xcela® PICC and NAMIC®
Fluid Management devices, help hospitals create clinical and
economic solutions for their patients. The Company distributes
its products worldwide and has its lead U.S. manufacturing
facility in Glens Falls, NY. For more information, please visit:
www.navilystmedical.com.
About Avista Capital Partners
Avista Capital Partners is a leading private equity firm with
offices in New York and Houston. Founded in 2005, Avista manages
$2.0 billion in private equity capital. Avista’s strategy is to
make controlling or influential minority investments primarily
in growth-oriented media, healthcare and energy companies.
Through its team of seasoned investment professionals and
industry experts, Avista seeks to invest in and add value to
well-positioned businesses with exceptional leadership. For more
information, visit http://www.avistacap.com.
|
| |
|
|
| |
|
|
